Cargando…

Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020

Pneumonia is the leading cause of death in children under 5 years of age worldwide. In this study, we primarily analyzed the hospitalization costs for children diagnosed with pneumonia in one of the leading public hospitals in Shanghai, China. Furthermore, factors affecting the hospitalization costs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Xu, Zhen-Hui, Lu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620989/
https://www.ncbi.nlm.nih.gov/pubmed/35653718
http://dx.doi.org/10.1080/21645515.2022.2081459
_version_ 1784821440121405440
author Wang, Jing
Xu, Zhen-Hui
Lu, Jin
author_facet Wang, Jing
Xu, Zhen-Hui
Lu, Jin
author_sort Wang, Jing
collection PubMed
description Pneumonia is the leading cause of death in children under 5 years of age worldwide. In this study, we primarily analyzed the hospitalization costs for children diagnosed with pneumonia in one of the leading public hospitals in Shanghai, China. Furthermore, factors affecting the hospitalization costs for children with pneumonia were evaluated. Data on case diagnosis, hospitalization time, age and various hospitalization expenses were collected. Total hospitalization expense for the 149 cases was $177,750, with an average total cost of $1,193 per person and an average out-of-pocket cost of $642. The highest per capita expenses included fees for laboratory diagnosis ($418), general medical service ($235), western medicine ($253), and antibacterial drugs ($158). The leading diagnosis was bronchopneumonia, with 68 (46%) cases, an average hospital stays of 7.4 days, and average hospitalization expenses of $1,068. Considering the high burden of pneumonia in children, hospitals and governments must make more reasonable use of limited resources of the medical system. At the same time, various types of medical insurance should be added into the children’s medical security system, encourage vaccination with pneumonia vaccines (13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine), and ensure that more children benefit from the vaccine by including it in the national immunization program.
format Online
Article
Text
id pubmed-9620989
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-96209892022-11-01 Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020 Wang, Jing Xu, Zhen-Hui Lu, Jin Hum Vaccin Immunother Pneumococcal – Short Report Pneumonia is the leading cause of death in children under 5 years of age worldwide. In this study, we primarily analyzed the hospitalization costs for children diagnosed with pneumonia in one of the leading public hospitals in Shanghai, China. Furthermore, factors affecting the hospitalization costs for children with pneumonia were evaluated. Data on case diagnosis, hospitalization time, age and various hospitalization expenses were collected. Total hospitalization expense for the 149 cases was $177,750, with an average total cost of $1,193 per person and an average out-of-pocket cost of $642. The highest per capita expenses included fees for laboratory diagnosis ($418), general medical service ($235), western medicine ($253), and antibacterial drugs ($158). The leading diagnosis was bronchopneumonia, with 68 (46%) cases, an average hospital stays of 7.4 days, and average hospitalization expenses of $1,068. Considering the high burden of pneumonia in children, hospitals and governments must make more reasonable use of limited resources of the medical system. At the same time, various types of medical insurance should be added into the children’s medical security system, encourage vaccination with pneumonia vaccines (13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine), and ensure that more children benefit from the vaccine by including it in the national immunization program. Taylor & Francis 2022-06-02 /pmc/articles/PMC9620989/ /pubmed/35653718 http://dx.doi.org/10.1080/21645515.2022.2081459 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Pneumococcal – Short Report
Wang, Jing
Xu, Zhen-Hui
Lu, Jin
Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020
title Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020
title_full Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020
title_fullStr Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020
title_full_unstemmed Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020
title_short Hospitalization costs for children with pneumonia in Shanghai, China from 2019 to 2020
title_sort hospitalization costs for children with pneumonia in shanghai, china from 2019 to 2020
topic Pneumococcal – Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620989/
https://www.ncbi.nlm.nih.gov/pubmed/35653718
http://dx.doi.org/10.1080/21645515.2022.2081459
work_keys_str_mv AT wangjing hospitalizationcostsforchildrenwithpneumoniainshanghaichinafrom2019to2020
AT xuzhenhui hospitalizationcostsforchildrenwithpneumoniainshanghaichinafrom2019to2020
AT lujin hospitalizationcostsforchildrenwithpneumoniainshanghaichinafrom2019to2020